Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.

被引：0
|
作者：
Moon, Helen H. [1 ]
Kearney, Mairead [2 ]
Mahmoudpour, Seyed Hamidreza [2 ]
Ike, Chiemeka [3 ]
Morris, Valerie A. [3 ]
Rava, Andrew [4 ]
Kim, Sonia [5 ]
Sun, Haiyan [5 ]
Boyd, Marley [5 ]
Rey, Gabriel Gomez [5 ]
机构：
[1] Kaiser Permanente, Riverside, CA USA
[2] Healthcare Business Merck KGaA, Darmstadt, Germany
[3] EMD Serono, Rockland, MA USA
[4] Genesis Res, Hoboken, NJ USA
[5] Genesis Res LLC, Hoboken, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-138-12268; 130-544; 261-492-9019; 298-145-222-9001; 261-492-3532-2370-7650-2700; 261-566-9263; 6; 4; 3; 2; 1880; 1876; 3224; 295; 12; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [31] Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden
    Bellmunt, Joaquim
    Powles, Thomas
    Park, Se Hoon
    Voog, Eric
    Valderrama, Begona Perez
    Gurney, Howard
    Ullen, Anders
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Sternberg, Cora N.
    Aragon-Ching, Jeanny B.
    Petrylak, Daniel P.
    Duran, Miguel A. Climent
    Tyroller, Karin
    Hoffman, Jason
    Jacob, Natalia
    Grivas, Petros
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).
    Barthelemy, Philippe
    Loriot, Yohann
    Voog, Eric
    Eymard, Jean Christophe
    Ravaud, Alain
    Flechon, Aude
    Jaillon, Christine Abraham
    Chasseray, Matthieu
    Lorgis, Veronique
    Hilgers, Werner
    Gobert, AurElien
    Le Moulec, Sylvestre
    Simon, Camille
    Nicolas, Emanuel
    Escande, Anne
    Pouessel, Damien
    Josse, Constant
    Solbes, Marie-Noelle
    Lambert, Prisca
    Thibault, Constance
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [33] Real-world data (RWD) with avelumab in patients (pts) with locally advanced or metastatic urothelial cancer (la-mUC): The AVEBLADDER study.
    Sotelo, Marta
    Pelaez, Mireia
    Basterretxea, Laura
    Varga, Estrella
    Sanchez-Escribano, Ricardo
    Pujol, Eduardo
    Santander, Carmen
    Martinez-Kareaga, Mireia
    Arruti Ibarbia, Mikel
    Rodriguez Ledesma, Inma
    Alvarez-Fernandez, Carlos
    Piedra, Pablo
    Calderero, Veronica
    Lainez, Nuria
    Verdun Aguilar, Juan Antonio
    Gil-Arnaiz, Irene
    Fernandez, Ricardo
    Mazas, Cristina
    Duran, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Real-world treatment (tx) patterns and clinical outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in Germany: Results of a retrospective observational study (CONVINCE)
    Machtens, Stefan
    Schlack, Katrin
    Kubin, Thomas
    Ruhnke, Markus
    Schulte, Clemens
    Eisen, Anna
    Osowski, Ulrike
    Guenther, Silke
    Kearney, Mairead
    Lipp, Rainer
    Schmitz, Stephan H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 551 - 551
  • [35] Overall survival and treatment patterns among real-world patients with locally advanced or metastatic urothelial carcinoma treated with first-line therapy
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    Horne, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [36] COST-EFFECTIVENESS OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT FOR LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN FINLAND
    Karttunen, E.
    Jaaskelainen, S.
    Hervonen, P.
    Chang, J.
    Kearney, M.
    VALUE IN HEALTH, 2022, 25 (01) : S99 - S99
  • [37] BUDGET IMPACT ANALYSIS OF AVELUMAB plus BEST SUPPORTIVE CARE (BSC) AS FIRST-LINE MAINTENANCE TREATMENT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN IRELAND
    Russell, L.
    Christoforou, K.
    McAlister, M.
    Alexopoulos, S.
    Bullement, A.
    VALUE IN HEALTH, 2022, 25 (12) : S140 - S140
  • [38] Retrospective database analysis of real-world treatment patterns and sequencing in locally advanced or metastatic urothelial carcinoma patients receiving sacituzumab govitecan
    Mamtani, R.
    Katz, J.
    An, R.
    Boateng, F.
    Ghazi, Y.
    Brockman, M.
    Sierecki, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1148 - S1149
  • [39] Real-world prescribing patterns for first-line and maintenance treatment of patients with advanced urothelial cancer (UC)
    Inderjeeth, Andrisha-Jade
    O'haire, Sophie
    Gibbs, Peter
    Wong, Lih-Ming
    Zhang, Alison
    Manohar, Paul
    James, Lynam
    Sengupta, Shomik
    Wong, Shirley
    Weickhardt, Andrew
    Tran, Ben
    Conduit, Ciara
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 95 - 95
  • [40] Real-world biomarker testing and first-line treatment patterns among locally advanced, unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma patients in the US.
    Wellen, Maria
    Luu, Tony
    Gleason, Michelle Kathleen
    Majer, Istvan Matyas
    Reading, Stephanie Rummans
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 348 - 348
12345